Boston, US – KCR has now become a member of the Clinical Data Interchange Standards Consortium (CDISC). CDISC is a global nonprofit organization that develops data standards to streamline clinical research and enable connections to healthcare. By becoming a member, KCR joins a group of professionals who are dedicated to improving the clinical research process.
CDISC drives global standards, bringing many different organizations into productive collaboration. The organization has established standards to support the acquisition, exchange, submission and archiving of clinical research data and metadata. This establishment of standards is to allow clinical research to work smarter by creating clarity and maximizing the value of data.
CDISC Standards are required for regulatory submissions to the Food and Drugs Administration (FDA) and are requested for use by the European Innovative Medicines Initiative (IMI).
Joining over 450 CDISC member organizations, KCR proves its commitment to delivering high-quality service according to the most up-to-date guidelines and best practices.
KCR is a contract research organization providing clinical development solutions for the pharmaceutical, biotechnology and medical device industries. The company supports clients with full-service capabilities across three main services: Trial Execution (TE), Functional Service Provision (FS) and Trial Execution Consulting (TC) over a broad range of therapeutic areas. KCR operates across four main regions: North America, Western Europe, Central Europe, and Eastern Europe with hubs located in Boston, U.S., Berlin, Germany, Warsaw, Poland and Kiev, Ukraine. KCR’s geographical locations allow for optimized delivery of trial execution strategies to develop life-changing therapies.
KCR: We see human behind every number.
Associate Director, PR & Marketing
mobile: (+48) 605 053 164